FDA Approved: LEUPROLIDE ACETATE — Original Application (UBI Pharma Inc.)

View source ↗

Summary

FDA approves Leuprolide acetate under an Original Application, establishing a generic version by UBI Pharma Inc. for the listed indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Central Precocious Puberty
• Endometriosis
• Prostate Cancer
• Uterine Fibroids

Drugs mentioned

• Leuprolide acetate (Leuprolide acetate)

Snippet

ORIG AP for LEUPROLIDE ACETATE (LEUPROLIDE ACETATE)